Depakine 200 mg/ml Oral solution 40 ml
47£
View analogs• Generalized and partial forms of epilepsy
• Juvenile myoclonic epilepsy
• Lennox-Gastaut syndrome.
Buy
Product quantities
Form of Release: Solution
Product Brand:
Sanofi Egypt
About the brand
Product Categories: Brain and cerebral circulation • Epilepsy
Depakine 200 mg/ml Oral solution 40 ml
Composition (per 1 ml of solution):
• Sodium Valproate — 200 mg.
Pharmacological properties:
Depakine has an anticonvulsant effect by increasing the level of gamma-aminobutyric acid (GABA) in the brain, the main inhibitory neurotransmitter.
• Suppresses excessive neuronal activity
• Effective for a wide range of seizure disorders
• Stabilizes mood in patients with bipolar disorder (off-label use).
Indications:
• Generalized and partial forms of epilepsy
• Juvenile myoclonic epilepsy
• Lennox-Gastaut syndrome.
Dosage and administration:
• Taken orally during or after meals
• Dosage is individualized:
• Children: 20–30 mg/kg/day
• Adults: starting dose 600 mg/day, with gradual increase
• Daily dose is usually divided into 2–3 administrations
• Use the supplied dosing syringe with a pink plunger.
Tags, Keywords:
Active Ingredients:
No comments yet. Be the first to write one.
Your comment will be published after moderation.
You’ll receive a notification to your email when someone replies.
Русский
English
عربي


